Clinical Trial

National Systemic Lupus Erythematosus Prospective Cohort, Saudi Arabia

Recruiting
View on ClinicalTrials.gov →
Summary
SLE disease in Saudi Arabia is yet not well defined especially in a population with high consanguinity and high inbreeding coefficient . Up until now, there has been no prospective cohort study for SLE patients in Saudi Arabia. As a result, current published literature is focused on retrospective chart reviews which are subjected to many forms of bias. so the investigator proposed this prospective registry which will follow open cohort study design aiming to provide better understanding of disease presentation, course and outcomes especially if complemented by detailed immunological, molecular, genetic and microbiome data.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2020-10-25.
Trial Details
NCT Number NCT04604990
Lead Sponsor King Saud University
Conditions SLE (Systemic Lupus)
Enrollment 1,000 participants
Start Date 2020-12-20
Primary Completion 2050-11-01 (estimated)
Study Completion 2050-11-01 (estimated)
Updated on ClinicalTrials.gov 2021-09-01